Skip to main content
. 2021 May 14;11:538927. doi: 10.3389/fonc.2021.538927

Figure 5.

Figure 5

Tumor mutation burden (TMB) analyses. (A) Comparison of the TMB value between T1–T2 and T3–T4 patients with bladder urothelial carcinoma. (B) Kaplan–Meier plots of recurrence free survival in high TMB (>10.4) and Low TMB (<10.4) patients with bladder urothelial carcinoma. TMB, tumor mutation burden.